Senior insider sale
Chief Commercial Officer at AKEBIA THERAPEUTICS, INC. — senior position signals high conviction
$118.3K
84.83K shares
What this filing means
GRUND NICHOLAS plans to sell 84.83K shares of AKEBIA THERAPEUTICS, INC. valued at approximately $118.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/2/2026ACC: 0001517022-26-000012
Officer· Chief Commercial Officer
Since Feb 2026
84.83K
Shares to sell
$118.3K
Approx. market value
84.83K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock
n/a
1/31/2026
84.83KTotal acquired84.83K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2026 | Restricted Stock n/a | 84.83K | — |
| Total | 84.83K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
84.83K
Market value
$118.3K
2/2/2026
Total
Units
84.83K
Value
$118.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/2/2026 | 84.83K | $118.3K | Nasdaq | Planned |
| Total | 84.83K | $118.3K | ||